Mark For: EPILOX® trademark registration is intended to cover the categories of pharmaceutical products and substances, namely, antirheumatic medications; antidementia medications; nootropic medications; antiepileptic medications; dehabituating medications; hypnotic and sedative medications; neuropathological preparations and other neurotropic medications; antispasmotic medications; anti-parkinson's medications and other medications effective against extrapyramidal disturbances; psychopharmacological medications; antihypertonic medications; medications for arteriosclerosis; beta-receptor blockers and calcium channel blockers; inhibitors of the renin-angiotensin system; diuretic medications; medications promoting circulation; lipid suppressors; gastrointestinal medications; medications for migraine; and urological medications. [all]
Status
2022-06-26 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
No
Filed ITU
Yes
44D Filed
No
44E Current
Yes
66A Current
No
Current Basis
No
No Basis
No
Cancellation Code
2
Domestic Representative
JACOBSON HOLMAN PLLC
Attorney Name
JOHN CLARKE HOLMAN
Attorney Docket Number
T33971US0
Law Office Assigned
L10
Employee Name
ABRAMS, JACQUELINE WIL
Timeline
2003-03-31
Application Filed
2004-01-20
Published
2004-01-20
Published for Opposition
2005-11-15
Location: PUBLICATION AND ISSUE SECTION
2005-11-15
Trademark Registered
2012-06-22
Cancelled
2012-06-22
Status: Dead/Cancelled
2012-06-22
Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
JOHN CLARKE HOLMAN JACOBSON HOLMAN PLLC THE JENIFER BUILDING 400 SEVENTH STREET, N.W. WASHINGTON, D.C. 20004-2201
Good, Services, and Codes
(CANCELLED) IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICAL PRODUCTS AND SUBSTANCES, NAMELY, ANTIRHEUMAT IC MEDICATIONS; ANTIDEMENTIA MEDICATIONS; NOOTROP IC MEDICATIONS; ANTIEPILEPT IC MEDICATIONS; DEHABITUATING MEDICATIONS; HYPNOT IC AND SEDATIVE MEDICATIONS; NEUROPATHOLOGICAL PREPARATIONS AND OTHER NEUROTROP IC MEDICATIONS; ANTISPASMOT IC MEDICATIONS; ANTI-PARKINSON'S MEDICATIONS AND OTHER MEDICATIONS EFFECTIVE AGAINST EXTRAPYRAMIDAL DISTURBANCES; PSYCHOPHARMACOLOGICAL MEDICATIONS; ANTIHYPERTON IC MEDICATIONS; MEDICATIONS FOR ARTERIOSCLEROSIS; BETA-RECEPTOR BLOCKERS AND CALCIUM CHANNEL BLOCKERS; INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM; DIURET IC MEDICATIONS; MEDICATIONS PROMOTING CIRCULATION; LIPID SUPPRESSORS; GASTROINTESTINAL MEDICATIONS; MEDICATIONS FOR MIGRAINE; AND UROLOGICAL MEDICATIONS
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
PHARMACEUTICAL PRODUCTS AND SUBSTANCES, NAMELY, ANTIRHEUMATIC MEDICATIONS; ANTIDEMENTIA MEDICATIONS; NOOTROPIC MEDICATIONS; ANTIEPILEPTIC MEDICATIONS; DEHABITUATING MEDICATIONS; HYPNOTIC AND SEDATIVE MEDICATIONS; NEUROPATHOLOGICAL PREPARATIONS AND OTHER NEUROTROPIC MEDICATIONS; ANTISPASMOTIC MEDICATIONS; ANTI-PARKINSON'S MEDICATIONS AND OTHER MEDICATIONS EFFECTIVE AGAINST EXTRAPYRAMIDAL DISTURBANCES; PSYCHOPHARMACOLOGICAL MEDICATIONS; ANTIHYPERTONIC MEDICATIONS; MEDICATIONS FOR ARTERIOSCLEROSIS; BETA-RECEPTOR BLOCKERS AND CALCIUM CHANNEL BLOCKERS; INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM; DIURETIC MEDICATIONS; MEDICATIONS PROMOTING CIRCULATION; LIPID SUPPRESSORS; GASTROINTESTINAL MEDICATIONS; MEDICATIONS FOR MIGRAINE; AND UROLOGICAL MEDICATIONS
Trademark Filing History
Description
Date
Proceeding Number
CANCELLED SEC. 8 (6-YR)
2012-06-22
REGISTERED-PRINCIPAL REGISTER
2005-11-15
1(B) BASIS DELETED; PROCEED TO REGISTRATION
2005-06-28
61813
NOTICE OF ALLOWANCE CANCELLED
2005-06-12
61813
PAPER RECEIVED
2005-06-01
NOA MAILED - SOU REQUIRED FROM APPLICANT
2005-05-03
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
2004-08-18
PAPER RECEIVED
2004-06-29
EXTENSION OF TIME TO OPPOSE RECEIVED
2004-02-13
PUBLISHED FOR OPPOSITION
2004-01-20
NOTICE OF PUBLICATION
2003-12-31
APPROVED FOR PUB - PRINCIPAL REGISTER
2003-11-17
PAPER RECEIVED
2003-10-15
CORRESPONDENCE RECEIVED IN LAW OFFICE
2003-10-15
NON-FINAL ACTION MAILED
2003-09-22
ASSIGNED TO EXAMINER
2003-09-16
65720
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.